Both PD-1 ligands protect the kidney from ischemia reperfusion injury

Journal of Immunology

Volumn 194, Issue 1, 2015, Pages 325-333

  Jaworska, Katarzyna ^a   Ratajczak, Joanna ^a   Huang, Liping ^a   Whalen, Kristen ^a   Yang, Mana ^a   Stevens, Brian K ^a   Kinsey, Gilbert R ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CXCL1 CHEMOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; KIDNEY INJURY MOLECULE 1; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; BLOCKING ANTIBODY; CD274 PROTEIN, MOUSE; CXCL1 PROTEIN, MOUSE; ICAM1 PROTEIN, MOUSE; PDCD1 PROTEIN, MOUSE; PDCD1LG2 PROTEIN, MOUSE; PROGRAMMED DEATH 1 RECEPTOR;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GENE EXPRESSION; INNATE IMMUNITY; KIDNEY DYSFUNCTION; KIDNEY INJURY; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NEPHRITIS; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; RENAL PROTECTION; REPERFUSION INJURY; UPREGULATION; ACUTE KIDNEY INJURY; ADOPTIVE TRANSFER; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; GENETICS; IMMUNOLOGY; INFLAMMATION; KIDNEY; KIDNEY FAILURE, CHRONIC; KNOCKOUT MOUSE; PATHOLOGY; TRANSPLANTATION;

ACUTE KIDNEY INJURY; ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, BLOCKING; ANTIGENS, CD274; CHEMOKINE CXCL1; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN; PROGRAMMED CELL DEATH 1 RECEPTOR; REPERFUSION INJURY; T-LYMPHOCYTES, REGULATORY;

EID: 84919629295     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400497     Document Type: Article

References (75)

1. Bellomo, R., J. A. Kellum, and C. Ronco. 2012. Acute kidney injury. Lancet 380: 756-766.
2. Liangos, O., R. Wald, J. W. O'Bell, L. Price, B. J. Pereira, and B. L. Jaber. 2006. Epidemiology and outcomes of acute renal failure in hospitalized patients: A national survey. Clin. J. Am. Soc. Nephrol. 1: 43-51.
3. Chawla, L. S., and P. L. Kimmel. 2012. Acute kidney injury and chronic kidney disease: An integrated clinical syndrome. Kidney Int. 82: 516-524.
4. Ishani, A., J. L. Xue, J. Himmelfarb, P.W. Eggers, P. L. Kimmel, B. A. Molitoris, and A. J. Collins. 2009. Acute kidney injury increases risk of ESRD among elderly. J. Am. Soc. Nephrol. 20: 223-228.
5. Kinsey, G. R., and M. D. Okusa. 2011. Pathogenesis of acute kidney injury: Foundation for clinical practice. Am. J. Kidney Dis. 58: 291-301.
6. Mao, H., N. Katz, W. Ariyanon, L. Blanca-Martos, Z. Adybelli, A. Giuliani, T. H. Danesi, J. C. Kim, A. Nayak, M. Neri, et al. 2013. Cardiac surgeryassociated acute kidney injury. Cardiorenal Med. 3: 178-199.
7. Burne, M. J., F. Daniels, A. El Ghandour, S. Mauiyyedi, R. B. Colvin, M. P. O'Donnell, and H. Rabb. 2001. Identification of the CD4+ T cell as a major pathogenic factor in ischemic acute renal failure. J. Clin. Invest. 108: 1283-1290.
8. Kelly, K. J., W. W. Williams, Jr., R. B. Colvin, S. M. Meehan, T. A. Springer, J. C. Gutierrez-Ramos, and J. V. Bonventre. 1996. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J. Clin. Invest. 97: 1056-1063.
9. Lai, L. W., K. C. Yong, S. Igarashi, and Y. H. Lien. 2007. A sphingosine-1- phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia-reperfusion injury. Kidney Int. 71: 1223-1231.
10. Lee, H. T., M. Kim, M. Kim, N. Kim, F. T. T. Billings, IV, V. D. D'Agati, and C. W. Emala, Sr. 2007. Isoflurane protects against renal ischemia and reperfusion injury and modulates leukocyte infiltration in mice. Am. J. Physiol. Renal Physiol. 293: F713-F722.
11. Li, L., L. Huang, S. S. Sung, P. I. Lobo, M. G. Brown, R. K. Gregg, V. H. Engelhard, and M. D. Okusa. 2007. NKT cell activation mediates neutrophil IFN-g production and renal ischemia-reperfusion injury. J. Immunol. 178: 5899-5911.
12. Li, L., L. Huang, S. S. Sung, A. L. Vergis, D. L. Rosin, C. E. Rose, Jr., P. I. Lobo, and M. D. Okusa. 2008. The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int. 74: 1526-1537.
13. Ramesh, G., and W. B. Reeves. 2002. TNF-Alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J. Clin. Invest. 110: 835-842.
14. Ferenbach, D. A., T. A. Sheldrake, K. Dhaliwal, T. M. Kipari, L. P. Marson, D. C. Kluth, and J. Hughes. 2012. Macrophage/monocyte depletion by clodronate, but not diphtheria toxin, improves renal ischemia/reperfusion injury in mice. Kidney Int. 82: 928-933.
15. Jang, H. R., and H. Rabb. 2009. The innate immune response in ischemic acute kidney injury. Clin. Immunol. 130: 41-50.
16. Lee, S., S. Huen, H. Nishio, S. Nishio, H. K. Lee, B. S. Choi, C. Ruhrberg, and L. G. Cantley. 2011. Distinct macrophage phenotypes contribute to kidney injury and repair. J. Am. Soc. Nephrol. 22: 317-326.
17. Li, L., L. Huang, A. L. Vergis, H. Ye, A. Bajwa, V. Narayan, R. M. Strieter, D. L. Rosin, and M. D. Okusa. 2010. IL-17 produced by neutrophils regulates IFN-g-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J. Clin. Invest. 120: 331-342.
18. Kinsey, G. R., R. Sharma, L. Huang, L. Li, A. L. Vergis, H. Ye, S. T. Ju, and M. D. Okusa. 2009. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J. Am. Soc. Nephrol. 20: 1744-1753.
19. Kinsey, G. R., L. Huang, K. Jaworska, K. Khutsishvili, D. A. Becker, H. Ye, P. I. Lobo, and M. D. Okusa. 2012. Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection. J. Am. Soc. Nephrol. 23: 1528-1537.
20. Kinsey, G. R., L. Huang, A. L. Vergis, L. Li, and M. D. Okusa. 2010. Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. Kidney Int. 77: 771-780.
21. Lee, H., D. Nho, H. S. Chung, H. Lee, M. K. Shin, S. H. Kim, and H. Bae. 2010. CD4+CD25+ regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice. Kidney Int. 78: 1100-1109.
22. Gandolfo, M. T., H. R. Jang, S. M. Bagnasco, G. J. Ko, P. Agreda, S. R. Satpute, M. T. Crow, L. S. King, and H. Rabb. 2009. Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int. 76: 717-729.
23. Kim, M. G., T. Y. Koo, J. J. Yan, E. Lee, K. H. Han, J. C. Jeong, H. Ro, B. S. Kim, S. K. Jo, K. H. Oh, et al. 2013. IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells. J. Am. Soc. Nephrol. 24: 1529-1536.
24. Deaglio, S., K. M. Dwyer, W. Gao, D. Friedman, A. Usheva, A. Erat, J. F. Chen, K. Enjyoji, J. Linden, M. Oukka, et al. 2007. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204: 1257-1265.
25. Polanczyk, M. J., C. Hopke, A. A. Vandenbark, and H. Offner. 2007. Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). Int. Immunol. 19: 337-343.
26. Vignali, D. A., L. W. Collison, and C. J. Workman. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8: 523-532.
27. Wing, K., Y. Onishi, P. Prieto-Martin, T. Yamaguchi, M. Miyara, Z. Fehervari, T. Nomura, and S. Sakaguchi. 2008. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.
28. Zhou, Q., M. E. Munger, S. L. Highfill, J. Tolar, B. J. Weigel, M. Riddle, A. H. Sharpe, D. A. Vallera, M. Azuma, B. L. Levine, et al. 2010. Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia. Blood 116: 2484-2493.
29. Francisco, L. M., P. T. Sage, and A. H. Sharpe. 2010. The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 236: 219-242.
30. Riella, L. V., A. M. Paterson, A. H. Sharpe, and A. Chandraker. 2012. Role of the PD-1 pathway in the immune response. Am. J. Transplant. 12: 2575-2587.
31. McGee, H. S., H. Yagita, Z. Shao, and D. K. Agrawal. 2010. Programmed death- 1 antibody blocks therapeutic effects of T-regulatory cells in cockroach antigeninduced allergic asthma. Am. J. Respir. Cell Mol. Biol. 43: 432-442.
32. Wang, W., R. Lau, D. Yu, W. Zhu, A. Korman, and J. Weber. 2009. PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25Hi regulatory T cells. Int. Immunol. 21: 1065-1077.
33. Brahmer, J. R., S. S. Tykodi, L. Q. M. Chow, W.-J. Hwu, S. L. Topalian, P. Hwu, C. G. Drake, L. H. Camacho, J. Kauh, K. Odunsi, et al. 2012. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 366: 2455-2465.
34. Sheridan, C. 2012. Cautious optimism surrounds early clinical data for PD-1 blocker. Nat. Biotechnol. 30: 729-730.
35. Topalian, S. L., F. S. Hodi, J. R. Brahmer, S. N. Gettinger, D. C. Smith, D. F. McDermott, J. D. Powderly, R. D. Carvajal, J. A. Sosman, M. B. Atkins, et al. 2012. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366: 2443-2454.
36. Dong, H., G. Zhu, K. Tamada, D. B. Flies, J. M. van Deursen, and L. Chen. 2004. B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes. Immunity 20: 327-336.
37. Shin, T., K. Yoshimura, T. Shin, E. B. Crafton, H. Tsuchiya, F. Housseau, H. Koseki, R. D. Schulick, L. Chen, and D. M. Pardoll. 2005. In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses. J. Exp. Med. 201: 1531-1541.
38. Wei, Q., and Z. Dong. 2012. Mouse model of ischemic acute kidney injury: Technical notes and tricks. Am. J. Physiol. Renal Physiol. 303: F1487-F1494.
39. Henderson, R. B., J. A. Hobbs, M. Mathies, and N. Hogg. 2003. Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood 102: 328-335.
40. Taylor, P. R., G. D. Brown, A. B. Geldhof, L. Martinez-Pomares, and S. Gordon. 2003. Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo. Eur. J. Immunol. 33: 2090-2097.
41. Ichimura, T., J. V. Bonventre, V. Bailly, H. Wei, C. A. Hession, R. L. Cate, and M. Sanicola. 1998. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem. 273: 4135-4142.
42. Lázár-Molnár, E., B. Chen, K. A. Sweeney, E. J. Wang, W. Liu, J. Lin, S. A. Porcelli, S. C. Almo, S. G. Nathenson, and W. R. Jacobs, Jr. 2010. Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc. Natl. Acad. Sci. USA 107: 13402-13407.
43. Mueller, S. N., V. K. Vanguri, S. J. Ha, E. E. West, M. E. Keir, J. N. Glickman, A. H. Sharpe, and R. Ahmed. 2010. PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice. J. Clin. Invest. 120: 2508-2515.
44. Dulos, J., G. J. Carven, S. J. van Boxtel, S. Evers, L. J. Driessen-Engels, W. Hobo, M. A. Gorecka, A. F. de Haan, P. Mulders, C. J. Punt, et al. 2012. PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer. J. Immunother. 35: 169-178.
45. Mcdermott, D. F., and M. B. Atkins. 2013. PD-1 as a potential target in cancer therapy. Cancer Med. 2: 662-673.
46. Alvarez, I. B., V. Pasquinelli, J. O. Jurado, E. Abbate, R. M. Musella, S. S. de la Barrera, and V. E. García. 2010. Role played by the programmed death-1- programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis. J. Infect. Dis. 202: 524-532.
47. Cho, H. Y., E. K. Choi, S. W. Lee, K. O. Jung, S. K. Seo, I. W. Choi, S. G. Park, I. Choi, and S. W. Lee. 2009. Programmed death-1 receptor negatively regulates LPS-mediated IL-12 production and differentiation of murine macrophage RAW264.7 cells. Immunol. Lett. 127: 39-47.
48. Ji, H., X. Shen, F. Gao, B. Ke, M. C. Freitas, Y. Uchida, R. W. Busuttil, Y. Zhai, and J. W. Kupiec-Weglinski. 2010. Programmed death-1/B7-H1 negative costimulation protects mouse liver against ischemia and reperfusion injury. Hepatology 52: 1380-1389.
49. Rui, Y., T. Honjo, and S. Chikuma. 2013. Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response. Proc. Natl. Acad. Sci. USA 110: 16073-16078.
50. Yao, S., S. Wang, Y. Zhu, L. Luo, G. Zhu, S. Flies, H. Xu, W. Ruff, M. Broadwater, I. H. Choi, et al. 2009. PD-1 on dendritic cells impedes innate immunity against bacterial infection. Blood 113: 5811-5818.
51. Brown, J. A., D. M. Dorfman, F. R. Ma, E. L. Sullivan, O. Munoz, C. R. Wood, E. A. Greenfield, and G. J. Freeman. 2003. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 170: 1257-1266.
52. Hobo, W., F. Maas, N. Adisty, T. de Witte, N. Schaap, R. van der Voort, and H. Dolstra. 2010. siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells. Blood 116: 4501-4511.
53. Li, L., and M. D. Okusa. 2010. Macrophages, dendritic cells, and kidney ischemia-reperfusion injury. Semin. Nephrol. 30: 268-277.
54. Li, L., L. Huang, H. Ye, S. P. Song, A. Bajwa, S. J. Lee, E. K. Moser, K. Jaworska, G. R. Kinsey, Y. J. Day, et al. 2012. Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury. J. Clin. Invest. 122: 3931-3942.
55. Tadagavadi, R. K., and W. B. Reeves. 2010. Renal dendritic cells ameliorate nephrotoxic acute kidney injury. J. Am. Soc. Nephrol. 21: 53-63.
56. Ding, H., X. Wu, and W. Gao. 2005. PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis. Clin. Immunol. 115: 184-191.
57. Schoop, R., P. Wahl, M. Le Hir, U. Heemann, M. Wang, and R. P. Wuthrich. 2004. Suppressed T-cell activation by IFN-g-induced expression of PD-L1 on renal tubular epithelial cells. Nephrol. Dial. Transplant. 19: 2713-2720.
58. Starke, A., M. T. Lindenmeyer, S. Segerer, M. A. Neusser, B. Rusi, D. M. Schmid, C. D. Cohen, R. P. Wuthrich, T. Fehr, and Y. Waeckerle-Men. 2010. Renal tubular PD-L1 (CD274) suppresses alloreactive human T-cell responses. Kidney Int. 78: 38-47.
59. Chen, Y., J. Zhang, G. Guo, Z. Ruan, M. Jiang, S. Wu, S. Guo, L. Fei, Y. Tang, C. Yang, et al. 2009. Induced B7-H1 expression on human renal tubular epithelial cells by the sublytic terminal complement complex C5b-9. Mol. Immunol. 46: 375-383.
60. Azuma, T., S. Yao, G. Zhu, A. S. Flies, S. J. Flies, and L. Chen. 2008. B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells. Blood 111: 3635-3643.
61. Liang, S. C., Y. E. Latchman, J. E. Buhlmann, M. F. Tomczak, B. H. Horwitz, G. J. Freeman, and A. H. Sharpe. 2003. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 33: 2706-2716.
62. Menke, J., J. A. Lucas, G. C. Zeller, M. E. Keir, X. R. Huang, N. Tsuboi, T. N. Mayadas, H. Y. Lan, A. H. Sharpe, and V. R. Kelley. 2007. Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: Distinct roles. J. Immunol. 179: 7466-7477.
63. Kielar, M. L., R. John, M. Bennett, J. A. Richardson, J. M. Shelton, L. Chen, D. R. Jeyarajah, X. J. Zhou, H. Zhou, B. Chiquett, et al. 2005. Maladaptive role of IL-6 in ischemic acute renal failure. J. Am. Soc. Nephrol. 16: 3315-3325.
64. Van Ginderachter, J. A., K. Movahedi, G. Hassanzadeh Ghassabeh, S. Meerschaut, A. Beschin, G. Raes, and P. De Baetselier. 2006. Classical and alternative activation of mononuclear phagocytes: Picking the best of both worlds for tumor promotion. Immunobiology 211: 487-501.
65. Lech, M., R. Gröbmayr, M. Ryu, G. Lorenz, I. Hartter, S. R. Mulay, H. E. Susanti, K. S. Kobayashi, R. A. Flavell, and H. J. Anders. 2014. Macrophage phenotype controls long-term AKI outcomes-kidney regeneration versus atrophy. J. Am. Soc. Nephrol. 25: 292-304.
66. Kuipers, H., F. Muskens, M. Willart, D. Hijdra, F. B. van Assema, A. J. Coyle, H. C. Hoogsteden, and B. N. Lambrecht. 2006. Contribution of the PD-1 ligands/ PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Eur. J. Immunol. 36: 2472-2482.
67. Butte, M. J., M. E. Keir, T. B. Phamduy, A. H. Sharpe, and G. J. Freeman. 2007. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27: 111-122.
68. Lai, L.-W., K.-C. Yong, and Y.-H. H. Lien. 2012. Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury. Kidney Int. 81: 983-992.
69. Habicht, A., S. Dada, M. Jurewicz, B. T. Fife, H. Yagita, M. Azuma, M. H. Sayegh, and I. Guleria. 2007. A link between PDL1 and T regulatory cells in fetomaternal tolerance. J. Immunol. 179: 5211-5219.
70. Li, P., L. Mao, X. Liu, Y. Gan, J. Zheng, A. W. Thomson, Y. Gao, J. Chen, and X. Hu. 2014. Essential role of program death 1-ligand 1 in regulatory T-cellafforded protection against blood-brain barrier damage after stroke. Stroke 45: 857-864.
71. Gotot, J., C. Gottschalk, S. Leopold, P. A. Knolle, H. Yagita, C. Kurts, and I. Ludwig-Portugall. 2012. Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo. Proc. Natl. Acad. Sci. USA 109: 10468-10473.
72. Bodhankar, S., Y. Chen, A. A. Vandenbark, S. J. Murphy, and H. Offner. 2013. PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1. J. Neuroinflammation 10: 111.
73. Dong, H., G. Zhu, K. Tamada, and L. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5: 1365-1369.
74. Tseng, S. Y., M. Otsuji, K. Gorski, X. Huang, J. E. Slansky, S. I. Pai, A. Shalabi, T. Shin, D. M. Pardoll, and H. Tsuchiya. 2001. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193: 839-846.
75. Wang, S., J. Bajorath, D. B. Flies, H. Dong, T. Honjo, and L. Chen. 2003. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J. Exp. Med. 197: 1083-1091.